Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;132(21-22):664-670.
doi: 10.1007/s00508-020-01734-6. Epub 2020 Sep 18.

SARS-CoV-2: recommendations for treatment in intensive care medicine

Affiliations

SARS-CoV-2: recommendations for treatment in intensive care medicine

Markus Köstenberger et al. Wien Klin Wochenschr. 2020 Nov.

Abstract

Coronavirus disease 2019 (COVID-19) progresses mildly in most of the cases; however, about 5% of the patients develop a severe acute respiratory distress syndrome (ARDS). Of all COVID-19 patients 3% need intensive care treatment, which becomes a great challenge for anesthesiology and intensive care medicine, medically, hygienically and for technical safety requirements. For these reasons, only experienced medical and nursing staff in the smallest grouping possible should be assigned. For these team members, a consistent use of personal protective equipment (PPE) is essential.Due to the immense medical challenges, the following treatment guidelines were developed by the ÖGARI (Österreichische Gesellschaft für Anästhesiologie, Reanimation und Intensivmedizin), FASIM (Federation of Austrian Societies of Intensive Care Medicine) and ÖGIAIN (Österreichische Gesellschaft für Internistische und Allgemeine Intensivmedizin und Notfallmedizin).The recommendations given in this article are to be understood as short snapshots of the moment; all basic guidelines are works in progress and will be regularly updated as evidence levels, new study results and additional experience are gathered.

Keywords: ARDS; COVID-19; Personal protective equipment; Respiratory therapy; SARS-CoV‑2.

PubMed Disclaimer

Conflict of interest statement

M. Köstenberger, W. Hasibeder, D. Dankl, R. Germann, C. Hörmann, M. Joannidis, K. Markstaller, S.‑O. Müller-Muttonen, S. Neuwersch-Sommeregger, E. Schaden, T. Staudinger, R. Ullrich, A. Valentin, and R. Likar declare that they have no competing interests.

References

    1. Köstenberger M, Hasibeder W, et al. ICU Therapy guideline for the treatment of patients with a SARS CoV2 infection. 2020. https://www.anaesthesie.news/wp-content/uploads/%C3%96GARI-FASIM-%C3%96G.... Accessed 30 Mar 2020.
    1. Alhazzani D, Hylander Moller M, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus disease 2019 (COVID-19) Intensive Care Med. 2020 doi: 10.1007/s00134-020-06022-5. - DOI - PMC - PubMed
    1. Laurer SA, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020;172(9):577–582. doi: 10.7326/M20-0504. - DOI - PMC - PubMed
    1. NHC. Diagnosis and treatment protocol for novel Coronavirus pneumonia. 2020. http://www.kankyokansen.org/uploads/uploads/files/jsipc/protocol_V7.pdf. Accessed 26 Mar 2020.
    1. Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA. 2020 doi: 10.1001/jama.2020.3633. - DOI - PubMed

LinkOut - more resources